Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinical and Vaccine Immunology : CVI|June 28, 2013
Immunogenicity analysis of Staphylococcus aureus clumping factor A genetic variantsRebecca A Brady, Christopher P Mocca, Drusilla L Burns
Clinical and Vaccine Immunology : CVI|February 28, 2014
Role of antibodies in protection elicited by active vaccination with genetically inactivated alpha hemolysin in a mouse model of staphylococcus aureus skin and soft tissue infectionsChristopher P Mocca, Rebecca A Brady, Drusilla L Burns
Mbio|February 9, 2024
Visualization of immune pathways that enhance the neutralizing antibody response to vaccines after primary immunizationAnita Verma, Roberto De Pascalis, Christopher P Mocca, et al.
Plos One|April 5, 2013
Stably luminescent Staphylococcus aureus clinical strains for use in bioluminescent imagingRoger D Plaut, Christopher P Mocca, Ranjani Prabhakara, et al.
Plos One|March 30, 2018
Comparison of the immune response during acute and chronic Staphylococcus aureus infectionRebecca A Brady, Christopher P Mocca, Roger D Plaut, et al.
Vaccine|June 16, 2022
Receptor-enhanced immunogenicity of anthrax protective antigen is primarily mediated by capillary morphogenesis Protein-2Anita Verma, Mahtab Moayeri, Christopher P Mocca, et al.
Plos One|May 10, 2013
Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infectionRebecca A Brady, Christopher P Mocca, Ranjani Prabhakara, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
A bicomponent Plasmodium falciparum investigational vaccine composed of protein-peptide conjugatesJoanna Kubler-Kielb, Fathy Majadly, Zuzana Biesova, et al.
Pageof 1